• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Regenerative Medicine

Medtronic announces Infuse spine trial

September 26, 2019 By Sean Whooley

Medtronic (NYSE:MDT) said today that it won FDA approval for a clinical trial of its Infuse bone graft in transforaminal lumbar interbody fusion spine procedures. The Minneapolis-based company started recruiting for the prospective, randomized pivotal trial, which is slated to enroll up to 1,000 patients. The TLIF trial would be the second clinical trial for Infuse, […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Orthopedics, Regenerative Medicine, Spine Tagged With: Medtronic

Frequency Therapeutics registers $100m IPO

September 9, 2019 By Sean Whooley

Frequency Therapeutics has registered an initial public offering of common stock worth $100 million. Woburn, Mass.-based Frequency Therapeutics did not disclose the number of shares it seeks to sell or the price range of the offered units. The company applied to the Securities and Exchange Commission have its common stock listed on The Nasdaq Global Market […]

Filed Under: Business/Financial News, Funding Roundup, Initial Public Offering (IPO), News Well, Otolaryngology/Ear, Nose & Throat (ENT), Research & Development, Stem Cells Tagged With: Frequency Therapeutics

AxoSim touts results of nerve-on-a-chip study

July 9, 2019 By Nancy Crotti

A new study of AxoSim’s Nerve-on-a-Chip technology shows that the platform accurately provides key physiological readouts that could help speed the development of drugs to treat neurological disorders. The study also shows that Nerve-on-a-Chip technology is the first all-human in vitro model that can measure critical factors that were formerly only available using live animal models. These […]

Filed Under: Featured, Neurological, Research & Development, Stem Cells Tagged With: axosim

Celling Spine acquires Link Spine

July 1, 2019 By Brad Perriello

Celling Biosciences subsidiary Celling Spine said today that it acquired the Link Spine assets from Link Orthopedics for an undisclosed amount. Austin, Texas-based Celling Spine said it plans to develop a “biologically enhanced” spinal fusion system using its in-house cell-based biologics and the Link Spine fusion system. “We have always maintained that the future of […]

Filed Under: Featured, Mergers & Acquisitions, Orthopedics, Regenerative Medicine, Spine, Wall Street Beat Tagged With: Celling Spine, Link Spine

MiMedx: Ex-managers cooked the books, went after whistleblowers

May 24, 2019 By Brad Perriello

The former management team at MiMedx (NSDQ:MDXG), led by ex-CEO Parker Petit, allegedly enacted a scheme to cook the books at the regenerative medicine company, retaliated against anyone who questioned their sketchy accounting practices and secretly filmed their offices, according to a probe the company launched after the scheme blew up last year. In February 2018, […]

Filed Under: Featured, Legal News, Regenerative Medicine, Wall Street Beat, Wound Care Tagged With: MiMedx Group Inc.

Report: Vericel to supply Epicel-based grafts for baby born without skin

May 15, 2019 By Fink Densford

Vericel (NSDQ:VCEL) is growing skin grafts using its Epicel product to help a baby born in Texas without skin, according to a recent Boston Business Journal report. The company said yesterday that it is creating grafts with its Epicel skin replacement product for newborn Ja’bari Gray, who has been in intensive care since being born earlier […]

Filed Under: Business/Financial News, Featured, Regenerative Medicine, Wound Care Tagged With: Vericel Corp

Histogenics completes transformation into Ocugen with $7m deal for NeoCart

May 13, 2019 By Brad Perriello

UPDATED May 14, 2019, with comment from Medavate. Histogenics (NSDQ:HSGX) said today that it completed another step on its transformation into clinical-stage biopharmaceutical company Ocugen, with a nearly $7 million deal to sell its NeoCart regenerative knee treatment to Medavate. The $6.5 million all-cash deal, signed May 8, will see all of the NeoCart assets pass […]

Filed Under: Featured, Mergers & Acquisitions, Orthopedics, Regenerative Medicine, Wall Street Beat Tagged With: Histogenics, Medavate, ocugen

Syntellix plans public listing on Singapore exchange

May 9, 2019 By Brad Perriello

German orthopedic implant maker Syntellix said today that it’s planning an initial public offering on the Singapore Stock Exchange and named a new CFO. Syntellix makes screws and pins from a magnesium-based material it developed, called Magnezix, that’s designed to be resorbed and converted into bone over time. Its products are approved in Mexico, Vietnam […]

Filed Under: Funding Roundup, Initial Public Offering (IPO), Orthopedics, Regenerative Medicine, Wall Street Beat Tagged With: Syntellix

Vericel inks licensing deal for MediWound’s NexoBrid, posts Q1 earnings

May 8, 2019 By Fink Densford

Vericel (NSDQ:VCEL) said yesterday it inked an exclusive U.S. licensing and supply agreement with MediWound (NSDQ:MDWD) for its NexoBrid biological product, and reported first quarter earnings that missed expectations on Wall Street. The NexoBrid is a topically-administered product intended to enzymatically remove nonviable burn tissue in patients with deep partial and full-thickness thermal burns. The product has […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Regenerative Medicine, Wall Street Beat, Wound Care Tagged With: MediWound, Vericel Corp

Misonix puts up $97m in stock for Solsys Medical

May 3, 2019 By Brad Perriello

Misonix (NSDQ:MSON) said yesterday that it put $97 million in stock on the table for Solsys Medical, formerly Soluble Systems, and its TheraSkin regenerative wound dressing. The deal calls for Farmingdale, N.Y.-based Misonix to issue 5.7 million new shares to Solsys stockholders, which would leave MSON investors owning 64% of the new company and former Solsys […]

Filed Under: Featured, MassDevice Earnings Roundup, Regenerative Medicine, Wall Street Beat, Wound Care Tagged With: Misonix, Solsys Medical

Smith & Nephew closes Osiris Therapeutics, Leaf Healthcare buys

April 17, 2019 By Fink Densford

Smith & Nephew (NYSE:SNN) said today that it closed both its $660 million acquisition of Osiris Therapeutics (NSDQ:OSIR) and its purchase of Leaf Healthcare and its Leaf Patient Monitoring System. The London-based company said that it paid $19 per share in cash for Osiris, which develops and produces regenerative medicine products including skin, bone grafts and articular […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Patient Monitoring, Regenerative Medicine, Wall Street Beat Tagged With: Leaf Healthcare, Osiris Therapeutics Inc., Smith & Nephew

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 52
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS